Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities?
Bladder cancer (BC) is the most common cancer involving the urinary system and the ninth most common cancer worldwide. Tobacco smoking is the most important environmental risk factor of BC. Several single nucleotide polymorphisms have been validated by genome-wide association studies as genetic risk factors for BC. However, the identification of DNA mismatch-repair genes, including MSH2 in Lynch syndrome and MUTYH in MUTYH-associated polyposis, raises the possibility of monogenic hereditary forms of BC. Moreover, other genetic mutations may play a key role in familial and hereditary transmissions of BC. Therefore, the aim of this review is to focus on the major hereditary syndromes involved in the development of BC and to report BC genetic susceptibilities established with genome-wide significance level.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Pharmacogenomics - 22(2021), 10 vom: 01. Juli, Seite 619-628 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Souaid, Tarek [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bladder cancer |
---|
Anmerkungen: |
Date Completed 10.02.2022 Date Revised 10.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.2217/pgs-2020-0165 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM325934118 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM325934118 | ||
003 | DE-627 | ||
005 | 20231225193510.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2217/pgs-2020-0165 |2 doi | |
028 | 5 | 2 | |a pubmed24n1086.xml |
035 | |a (DE-627)NLM325934118 | ||
035 | |a (NLM)34044612 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Souaid, Tarek |e verfasserin |4 aut | |
245 | 1 | 0 | |a Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities? |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.02.2022 | ||
500 | |a Date Revised 10.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Bladder cancer (BC) is the most common cancer involving the urinary system and the ninth most common cancer worldwide. Tobacco smoking is the most important environmental risk factor of BC. Several single nucleotide polymorphisms have been validated by genome-wide association studies as genetic risk factors for BC. However, the identification of DNA mismatch-repair genes, including MSH2 in Lynch syndrome and MUTYH in MUTYH-associated polyposis, raises the possibility of monogenic hereditary forms of BC. Moreover, other genetic mutations may play a key role in familial and hereditary transmissions of BC. Therefore, the aim of this review is to focus on the major hereditary syndromes involved in the development of BC and to report BC genetic susceptibilities established with genome-wide significance level | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Lynch | |
650 | 4 | |a bladder cancer | |
650 | 4 | |a genetics | |
650 | 4 | |a hereditary | |
650 | 4 | |a syndrome | |
700 | 1 | |a Hindy, Joya-Rita |e verfasserin |4 aut | |
700 | 1 | |a Diab, Ernest |e verfasserin |4 aut | |
700 | 1 | |a Kourie, Hampig Raphael |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d 2000 |g 22(2021), 10 vom: 01. Juli, Seite 619-628 |w (DE-627)NLM111671396 |x 1744-8042 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2021 |g number:10 |g day:01 |g month:07 |g pages:619-628 |
856 | 4 | 0 | |u http://dx.doi.org/10.2217/pgs-2020-0165 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2021 |e 10 |b 01 |c 07 |h 619-628 |